Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN)

21 filings reported holding LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share as of Q3 2025.
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 529,307 shares of 5,555,556 outstanding shares and own 9.53% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (221,867 shares), BlackRock, Inc. (89,272 shares), GEODE CAPITAL MANAGEMENT, LLC (61,076 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (46,761 shares), RENAISSANCE TECHNOLOGIES LLC (36,097 shares), STATE STREET CORP (18,626 shares), CITADEL ADVISORS LLC (14,247 shares), NORTHERN TRUST CORP (13,160 shares), DIMENSIONAL FUND ADVISORS LP (12,140 shares), and BARCLAYS PLC (9,412 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.